Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000543467 | SCV000631150 | pathogenic | Baller-Gerold syndrome | 2023-12-15 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Val1026Cysfs*18) in the RECQL4 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RECQL4 are known to be pathogenic (PMID: 12734318, 12952869). This variant is present in population databases (rs386833852, gnomAD 0.004%). This premature translational stop signal has been observed in individual(s) with RAPADILINO syndrome (PMID: 18716613). ClinVar contains an entry for this variant (Variation ID: 56407). For these reasons, this variant has been classified as Pathogenic. |
Ce |
RCV001092986 | SCV001249748 | pathogenic | not provided | 2019-10-01 | criteria provided, single submitter | clinical testing | |
Juha Muilu Group; Institute for Molecular Medicine Finland |
RCV000049820 | SCV000082229 | probable-pathogenic | Rapadilino syndrome | no assertion criteria provided | not provided | Converted during submission to Likely pathogenic. |